Australia's largest stock trading and investment forum Australia's #1 stock forum

BIT

0.00%

1.9¢ biotron limited

Ann: Bit225 Covid-19 Human Study Commenced, page-64

First 64 Last

Share
Profile

Follow
Oaktree16

3,191 Posts.

353

14/09/22

17:54

Post #: 63700665
Share

Originally posted by GiddyYup: ↑

I'm not entirely sure she is hanging onto that MK. In fact quite the opposite. 4 Weeks ago the BOD said the following:

"The directors have prepared cash flow projections that support the ability of the Company to continue as a going concern for the period 1 July 2022 to 31 August 2023. These cash flow projections include significant ongoing expenditure on research and development activities and assume the Company receives the research and development (‘R&D’) rebate from the Australian Government and sufficient additional funding from shareholders or other parties. If such funding is not achieved, the Company plans to reduce expenditures inline with available funding."

I think they have made it very clear that there is a capital raising coming. Unfortunately there are some posters who scream blue bloody murder if anybody dares mention it. It didn't fit into their story line over free grant money to fund the covid trial, which we now know was BS. The auditors hinted that there are concerns from the advisors, presumably due to timing and the current market conditions.

Its not a matter of "if" but "when" and at what price. The general market is very aware of this which is what has been keeping a cap on the SP for a while now. When you are down to your last few dollars the market tends to fixate on one thing and one thing only, ie what price will new shares be issued at.

Expand

Agree with the raise part.

BIT Price at posting: 5.7¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 125 more messages in this thread...

First 64 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$7.664K	403.3K

Buyers (Bids)

No.	Vol.	Price($)
1	100000	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	1202498	5

View Market Depth

No.	Vol.	Price($)
1	100000	0.019
10	1774771	0.018
10	1139476	0.017
12	3734154	0.016
10	1205000	0.015

Price($)	Vol.	No.
0.020	1052498	3
0.021	500000	1
0.022	1431102	4
0.023	1100772	2
0.024	153949	2

Last trade - 13.42pm 27/09/2024 (20 minute delay)

BIT (ASX) Chart

Ann: Bit225 Covid-19 Human Study Commenced, page-64

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Bit225 Covid-19 Human Study Commenced, page-64

Top Stories

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News